Press Releases
PCMA Supports Trump Administration’s Action to Increase Biosimilars Access
(Washington, D.C.) – The Trump Administration is taking action to increase access to biosimilars. Congress can take the administration’s lead and
The Devastating Patient Effects of Forced Pharmacy Closure Policy
(Washington, D.C) – Several state legislatures and some federal lawmakers have considered a dangerous policy, known as “Forced Pharmacy Closure,” that
PCMA Statement on Drug Pricing in President Trump’s State of the Union Address
In his State of the Union address Tuesday night, President Donald Trump spoke about the need to lower drug prices
New Survey Shows Employers Overwhelmingly Satisfied with PBMs
Employers report high satisfaction with drug savings PBMs get and the transparency they provide (Washington, D.C.) — A new survey released
Independent Pharmacies Increase in 2026
(Washington, D.C.) — Today, the Pharmaceutical Care Management Association (PCMA) released new data that provides a snapshot of the health of
PBM Reform is Done… Now What?
MEMORANDUM To: Interested Parties From: Brendan Buck, PCMA Re: PBM Reform is Done… Now What? Date: February 3, 2026 Today’s the
PCMA: Big Pharma Wins Big with Passage of PBM and Employer Mandates
(Washington, D.C.) — Today, the Senate passed a government funding bill that includes unrelated new mandates on employers and pharmacy benefit
PCMA Remarks on FL OIR PBM Exam Summary Report
(Tallahassee, FL) — Last month, the Florida Office of Insurance Regulation (OIR) published a Summary Report regarding market conduct exams of
